Ingredient or product comparison
GHK-Cu vs Other Research Peptides: Mechanism Comparison
Every research-grade peptide supplier should provide mechanism-of-action documentation. Not just amino acid sequence. The comparison below maps five commonly used cosmetic research peptides by their primary biological pathway, receptor/enzyme target, and measu
This source-based comparison does not add ratings or recommend a winner.
- Every research-grade peptide supplier should provide mechanism-of-action documentation. Not just amino acid sequence. The comparison below maps five commonly used cosmetic research peptides by their primary biological pathway, receptor/enzyme target, and measurable cellular outcome. We've found that protocol design failures most often occur when researchers assume functional equivalence between peptides that operate through unrelated mechanisms.
- GHK-Cu
- Copper ion chelation + histone acetylation
- Lysyl oxidase, SOD1, Nrf2, HATs
- Collagen cross-linking density ↑ 230%, MMP-1 ↓ 36%, SOD activity ↑ 180%
- Direct. Cu²⁺ is the active cofactor
- The only peptide that modulates both synthesis and structural stability through metalloenzyme activation
- Matrixyl (Pal-KTTKS)
- TGF-β receptor agonism
- SMAD2/3 pathway
- COL1A1 mRNA ↑ 117%, fibronectin ↑ 86%, no MMP suppression
- None. Synthetic signal peptide
- Upregulates collagen transcription without affecting post-translational processing or oxidative protection
- Argireline (Ac-EEMQRR)
- SNARE complex inhibition
- SNAP-25 protein
- Acetylcholine vesicle fusion ↓ 42% in vitro
- None. Neurotransmitter modulator
- Reduces muscle contraction signalling. No overlap with extracellular matrix pathways
- Copper Peptide GHK (no copper)
- Weak TGF-β signalling
- Uncertain. Less characterised
- Minor collagen upregulation, inconsistent across studies
- Absent. Tripeptide lacks coordinated Cu²⁺
- The peptide backbone without copper shows minimal activity compared to the copper complex
- Leuphasyl (Penta-peptide-18)
- Enkephalin receptor agonism
- δ-opioid receptors on neurons
- Muscle contraction reduction (similar to argireline mechanism)
- None. Neuropeptide analogue
- Another neurotransmitter pathway modulator with no matrix synthesis involvement
- This table underscores a critical protocol design principle: peptide selection must align with the biological outcome you're measuring. If your research objective is collagen fibre tensile strength or oxidative damage resistance, GHK-Cu engages the relevant enzymes. If you're measuring collagen gene transcription in isolation, matrixyl may produce higher fold-change in mRNA without improving structural outcomes. If neuromuscular contraction is the endpoint, argireline and leuphasyl are appropriate. But they won't affect matrix remodelling.
- Real Peptides supplies each of these compounds at >98% purity verified by HPLC and mass spectrometry. Because mechanism specificity depends on molecular integrity. A degraded peptide or one contaminated with synthesis byproducts won't bind its target enzyme or receptor with the affinity the published literature reports. We've reviewed third-party testing across hundreds of peptide batches in this category. The variability in supplier purity is the single largest source of inconsistent research outcomes.